Effect of Cranberry Capsules on Urinary Infection Rates in Spinal Cord Injured Patients During Post Acute Rehabilitation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to establish whether cranberry capsules reduce rates of urinary tract infections during initial rehabilitation immediately after spinal cord injury.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery

NCT03898310

Urinary Tract Infections Incontinence

COMPLETED NA

Vitamin C for Prevention of Urinary Tract Infections in the Spinal Cord Injured

NCT00869427

Urinary Tract Infection Spinal Cord Injury

TERMINATED PHASE4

Cranberry Effect on Urinary Tract Infections

NCT02996981

Urinary Tract Infections

COMPLETED

Cranberry on Urinary Tract Infections

NCT01881165

Urinary Tract Infection

WITHDRAWN PHASE4

Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections

NCT01776021

Urinary Tract Infections Infection Urologic Diseases

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injury Urinary Tract Infection Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cranberry capsule

Group Type EXPERIMENTAL

Cranberry capsules

Intervention Type DIETARY_SUPPLEMENT

Cranberry capsules, 550mg, or placebo capsules, two capsules three times daily during in-patient rehabilitation

Placebo capsule

Group Type PLACEBO_COMPARATOR

Cranberry capsules

Intervention Type DIETARY_SUPPLEMENT

Cranberry capsules, 550mg, or placebo capsules, two capsules three times daily during in-patient rehabilitation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cranberry capsules

Cranberry capsules, 550mg, or placebo capsules, two capsules three times daily during in-patient rehabilitation

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Previously essentially healthy
2. Newly acquired spinal cord injury, T12 level or higher
3. Receiving in-patient care on the rehabilitation ward.
4. Expected admission duration \>= 4 weeks
5. 16 years old or older

Exclusion Criteria

1. Current or previous disorder that increases the risk of urinary tract infection including diabetes, urological disorder, previous operation on urinary tracts or kidneys, immune dysfunction
2. Severe head injury with impairment of cognitive function
3. Allergy to cranberry
4. Renal failure
5. Warfarin (Coumarin) treatment with unstable INR
6. Current symptomatic urinary tract infection

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No